Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Google-Funded 23andMe Launches, Offers $999 DNA Test
Link ID 937
Title Google-Funded 23andMe Launches, Offers $999 DNA Test
Url http://www.medscape.com/viewarticle/566252?src=rss
Description Google Inc-funded 23andMe launched on Monday and began offering a DNA saliva test for $999 per person, which would help users of the online site learn about their genes, inherited traits, family trees, and participate in research. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Nov 20, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Sargramostim Liquid Injection Withdrawn From US Market
  The edetate disodium component of Leukine has been linked to increased reports of adverse reactions, including syncope. Medscape Medical News
Category:   Articles > Business of Medicine


2. Does Transfusion With "Old" Blood Place the Surgical Patient at Risk?
  Commentary on a study on duration of stored transfusion blood and surgical outcomes, published March 20, 2008 in The New England Journal of Medicine
Medscape General Surgery
Category:   Articles > Business of Medicine


3. Forensic Nursing: Part 2. Inside Forensic Nursing
  Discover the relatively new specialty of forensic nursing through the eyes of practicing forensic nurses.
Medscape Nurses
Category:   Articles > Business of Medicine


4. U.S. Approves UnitedHealth Buying Sierra Health
  Insurer UnitedHealth Group Inc won U.S. antitrust approval on Monday to buy Sierra Health Services Inc, despite criticism of the deal. Reuters Health Information
Category:   Articles > Business of Medicine


5. UnitedHealth 1st-Qtr Profit Misses, Cuts Forecast
  Health insurer UnitedHealth Group Inc posted a lower-than-expected first-quarter profit on Tuesday, hurt by weakness in its business serving employers, and slashed its full-year earnings forecast, sending its shares down as much as 11.5 percent. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS